(JAZZ) Jazz Pharmaceuticals - Performance 0.4% in 12m
JAZZ performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-18.28%
#79 in Peer-Group
Rel. Strength
39.21%
#4515 in Stock-Universe
Total Return 12m
0.40%
#75 in Peer-Group
Total Return 5y
-2.45%
#67 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 14.7 |
| P/E Forward | 12.4 |
| High / Low | USD |
|---|---|
| 52 Week High | 144.17 USD |
| 52 Week Low | 97.78 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 30.71 |
| Buy/Sell Signal +-5 | -1.28 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: JAZZ (0.4%) vs XLV (-6%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-5.69% | 124% | 337% | 64.3 | 57.8 | 0.61 | 23.7% | -5.15% |
| LLY NYSE Eli Lilly |
7.32% | -14.6% | 405% | 63.3 | 35.6 | 1.19 | 58.2% | 18.9% |
| NVS NYSE Novartis |
6.6% | 16.7% | 77.9% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| NOVN SW Novartis |
2.29% | 3% | 48.6% | 18.4 | 13.9 | 1.36 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-3.55% | 4.95% | 48.8% | 18.6 | 8.61 | 0.38 | -25.2% | 3.11% |
| SFZN SW Siegfried Holding |
-7.76% | -5.21% | 112% | 26.1 | 25 | 1.48 | 77.8% | 77.6% |
| AZN NASDAQ AstraZeneca |
-1.44% | -8.57% | 48.1% | 28.5 | 15.7 | 0.95 | 52.7% | 22.3% |
| IPN PA Ipsen |
1.55% | -9.51% | 43.2% | 24.1 | 10.2 | 0.73 | -6.40% | -6.33% |
Performance Comparison: JAZZ vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for JAZZ
| Total Return (including Dividends) | JAZZ | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -1.26% | 1.67% | 4.52% |
| 3 Months | -13.89% | -7.84% | 10.25% |
| 12 Months | 0.40% | -6.02% | 14.16% |
| 5 Years | -2.45% | 47.32% | 116.91% |
| Trend Score (consistency of price movement) | JAZZ | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -56.8% | 41.7% | 79.1% |
| 3 Months | -5.2% | -51% | 91.7% |
| 12 Months | 12.5% | -70.9% | 44% |
| 5 Years | -64.4% | 88% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th44.04 | -2.88% | -5.53% |
| 3 Month | %th21.76 | -6.57% | -21.90% |
| 12 Month | %th62.18 | 6.83% | -12.05% |
| 5 Years | %th64.25 | -33.78% | -55.03% |
FAQs
Does Jazz Pharmaceuticals (JAZZ) outperform the market?
Yes,
over the last 12 months JAZZ made 0.40%, while its related Sector, the Health Care Sector SPDR (XLV) made -6.02%.
Over the last 3 months JAZZ made -13.89%, while XLV made -7.84%.
Performance Comparison JAZZ vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
JAZZ vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -2.3% | -5.8% | -18.2% | -14% |
| US NASDAQ 100 | QQQ | -3% | -6.8% | -19.7% | -14% |
| German DAX 40 | DAX | -3.2% | -1.6% | -33.4% | -30% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -1.7% | -3.8% | -14.2% | -16% |
| Hongkong Hang Seng | HSI | -2.7% | -8.1% | -35.4% | -35% |
| India NIFTY 50 | INDA | -2.7% | -3.6% | -19.2% | 0% |
| Brasil Bovespa | EWZ | -1.6% | -4.7% | -39.9% | -10% |
JAZZ vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -3.5% | -8.2% | -24.5% | -27% |
| Consumer Discretionary | XLY | -1.8% | -3.2% | -10.2% | -20% |
| Consumer Staples | XLP | 1.2% | -0% | -17.1% | -8% |
| Energy | XLE | 1% | -5.8% | -15.6% | 4% |
| Financial | XLF | -2.1% | -3.8% | -21.4% | -28% |
| Health Care | XLV | -1.2% | -2.9% | -11.5% | 6% |
| Industrial | XLI | -1.9% | -4.4% | -25% | -23% |
| Materials | XLB | -1% | -3.6% | -19% | -3% |
| Real Estate | XLRE | 2.4% | -0.8% | -16.6% | -11% |
| Technology | XLK | -3.1% | -9.7% | -20.4% | -10% |
| Utilities | XLU | 0% | -2.3% | -21.9% | -23% |
| Aerospace & Defense | XAR | -4.2% | -10.9% | -39.3% | -52% |
| Biotech | XBI | -0.8% | -4.4% | -5.4% | 11% |
| Homebuilder | XHB | -1% | -5.1% | -7.7% | -0% |
| Retail | XRT | -0.1% | -3.4% | -10.8% | -6% |
JAZZ vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 4.2% | -10.3% | -11.0% | 11% |
| Natural Gas | UNG | 1.9% | -4.7% | -4.8% | 1% |
| Gold | GLD | 3.3% | 0.2% | -38.3% | -39% |
| Silver | SLV | 1.2% | -8.9% | -36.5% | -21% |
| Copper | CPER | -3.2% | -9.9% | -36.6% | -15% |
JAZZ vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -0.6% | -3.1% | -14.4% | -1% |
| iShares High Yield Corp. Bond | HYG | -0.4% | -2.8% | -17.7% | -10% |